Autopsy report · NCT02284737

A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH

“Lack of subjects.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years 8 months before it stopped.
• 100 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Nanjing First Hospital, Nanjing Medical University

Sponsor type

University, hospital or other

Conditions

Pulmonary Arterial Hypertension

Interventions

PADN; sham PADN; Sildenafil

Participants

100

Sites

1

Countries

China

Trials that died the same way

• Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
  “Lack of eligible subjects.” (83% match in meaning)
• Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
  “Not enough subjects.” (80% match in meaning)
• Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury
  “Lack of study participants.” (79% match in meaning)
• PK Intravenous Lidocaine Infusion
  “Lack of available study participants.” (72% match in meaning)
• Modified Functional Magnetic Stimulation Treatment for Constipation Improvement
  “no sufficient subjects” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.